title: Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable.
authors.affiliation: Department of Hematology, Erasmus University Medical Center Rotterdam, The Netherlands.
authors.forename: F W G
authors.initials: FW
authors.lastname: Leebeek
authors.forename: E
authors.initials: E
authors.lastname: Boersma
authors.forename: C P
authors.initials: CP
authors.lastname: Cannon
authors.forename: F J J
authors.initials: FJ
authors.lastname: van de Werf
authors.forename: M L
authors.initials: ML
authors.lastname: Simoons
mesh_terms: D000284:Administration, Oral; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex